Specialty Pharmacy

Findings suggest an association between lower disease activity and a higher intake of fish.

New diagnoses and prevalence of HIV is illustrated by demographics, location, and social determinants of health.

A look at last week's top stories in the world of pharmacy.

Multilayer hydrogel cubes provide a potential solution for the poor solubility and low bioavailability of an anti-cancer drug.

HIV disproportionately affects blacks and Latinos, who are less likely to receive ongoing care.

CT-P10 is indicated to treat rheumatoid arthritis, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangi.

Top articles of the week from Specialty Pharmacy Times.

Low testosterone found to increase the prevalence of chronic diseases among prostate cancer survivors.

Accumulation of gene mutations occurs in some patients with rheumatoid arthritis, study finds.

An estimated 200 orphan drug designation requests are pending FDA review.

CTL019 is an investigational chimeric antigen receptor T cell therapy.

The CEO of the Cutaneous Lymphoma Foundation describes the challenges of living with the disease.

Sarilumab (Kevzara) is a humanized monoclonal antibody that treats moderate-to-severe active RA.

Study explores the impact of tumor mutation burden and PD-L1 status in immunotherapy response.

The guidelines aim to reduce the risk of infection in patients administered anti-rheumatic medication.

Top news of the day from across the health care landscape.

More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.

The new tool aims to help patients make more informed treatment decisions and manage expectations following a cancer diagnosis.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, explores the benefits of incorporating specialty pharmacists into care teams.

Combining oncolytic virotherapy with PD-1 blockades shows promise treating rhabdomyosarcoma.

The tool can help reduce the cost of treatment for rheumatoid arthritis.

Top news of the day from across the health care landscape.

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.

Investigational drug demonstrates a substantial and clinically meaningful reduction in bleeds related to hemophilia.

The National HIV Testing Day annual campaign takes place on June 27th.

Data suggests favorable tolerability of novel treatment in patients with relapsed or refractory AML.

Rational design approaches could transform how multiple sclerosis is treated.

Top news of the day from across the health care landscape.

Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.

CT-P10 is indicated to treat a form of non-Hodgkin lymphoma and rheumatoid arthritis.